Save your place

Sign in to WhoBought

Please try again later.

Lexeo Therapeutics, Inc. Common Stock (LXEO) institutional ownership

Latest close $4.66 Jul 21, 2026
Market cap$153M 52-week range SectorHealthcare
Funds holding · Q1 2026
138
reported LXEO position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
74 buyers · 64 sellers

Lexeo Therapeutics, Inc. Common Stock (LXEO) price and institutional activity

Dates

Q1 2026

$0 bought by 74 investors
Affinity Asset Advisors, LLCOrbimed Advisors LLC +72 more
$0 sold by 64 investors
Avoro Capital Advisors LLCSiren, L.L.C. +62 more
Bought Sold Totals per quarter; hover a bar for the names.

Lexeo Therapeutics, Inc. Common Stock (LXEO) institutional activity · 138

Investor Type Est. change Change Δ Own Date
Affinity Asset Advisors, LLC · Added
Change +1.9M Date Q1 2026
Affinity Asset Advisors, LLC Added· Q1 2026 +1.9M Q1 2026
Orbimed Advisors LLC · Added
Change +1.5M Date Q1 2026
Orbimed Advisors LLC Added· Q1 2026 +1.5M Q1 2026
Avoro Capital Advisors LLC · Reduced
Change −1.4M Date Q1 2026
Avoro Capital Advisors LLC Reduced· Q1 2026 −1.4M Q1 2026
Paradigm Biocapital Advisors LP · Added
Change +1.4M Date Q1 2026
Paradigm Biocapital Advisors LP Added· Q1 2026 +1.4M Q1 2026
Goldman Sachs Group Inc · Added
Change +1.2M Date Q1 2026
Goldman Sachs Group Inc Added· Q1 2026 +1.2M Q1 2026
Spruce Street Capital LP · Added
Change +754K Date Q1 2026
Spruce Street Capital LP Added· Q1 2026 +754K Q1 2026
Siren, L.L.C. · Exited
Change −721K Δ Own −100.0% Date Q1 2026
Siren, L.L.C. Exited· Q1 2026 −721K −100.0% Q1 2026
Millennium Management LLC · Added
Change +705K Date Q1 2026
Millennium Management LLC Added· Q1 2026 +705K Q1 2026
Octagon Capital Advisors LP · Reduced
Change −625K Date Q1 2026
Octagon Capital Advisors LP Reduced· Q1 2026 −625K Q1 2026
Silverarc Capital Management, LLC · Exited
Change −618K Δ Own −100.0% Date Q1 2026
Silverarc Capital Management, LLC Exited· Q1 2026 −618K −100.0% Q1 2026
Janus Henderson Group PLC · Reduced
Change −533K Date Q1 2026
Janus Henderson Group PLC Reduced· Q1 2026 −533K Q1 2026
D. E. Shaw & Co., Inc. · Reduced
Change −450K Δ Own −93.7% Date Q1 2026
D. E. Shaw & Co., Inc. Reduced· Q1 2026 −450K −93.7% Q1 2026
Woodline Partners LP · Reduced
Change −447K Date Q1 2026
Woodline Partners LP Reduced· Q1 2026 −447K Q1 2026
Verition Fund Management LLC · Exited
Change −428K Δ Own −100.0% Date Q1 2026
Verition Fund Management LLC Exited· Q1 2026 −428K −100.0% Q1 2026
Invesco Ltd. · Reduced
Change −400K Δ Own −86.3% Date Q1 2026
Invesco Ltd. Reduced· Q1 2026 −400K −86.3% Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 138

Famous investor activity in Lexeo Therapeutics, Inc. Common Stock (LXEO)

Lexeo Therapeutics, Inc. Common Stock (LXEO) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Tamayo Louis Edward · Officer Sell −$21K
Price $4.49 Qty −5K Owned 97K ΔOwn −4.6% Trade date Jul 1, 2026 Filed date Jul 1, 2026
Tamayo Louis Edward Officer Sell $4.49 −5K −$21K 97K −4.6% Jul 1, 2026 Jul 1, 2026
Otero Jose Manuel · Officer Sell −$21K
Price $4.48 Qty −5K Owned 137K ΔOwn −3.3% Trade date Jul 1, 2026 Filed date Jul 1, 2026
Otero Jose Manuel Officer Sell $4.48 −5K −$21K 137K −3.3% Jul 1, 2026 Jul 1, 2026
Bhalla Narinder Pal · Officer Sell −$99K
Price $4.42 Qty −22K Owned 82K ΔOwn −21.3% Trade date Jul 1, 2026 Filed date Jul 1, 2026
Bhalla Narinder Pal Officer Sell $4.42 −22K −$99K 82K −21.3% Jul 1, 2026 Jul 1, 2026
Townsend Richard Nolan · Director Sell −$116K
Price $4.48 Qty −26K Owned 378K ΔOwn −6.4% Trade date Jul 1, 2026 Filed date Jul 1, 2026
Townsend Richard Nolan Director Sell $4.48 −26K −$116K 378K −6.4% Jul 1, 2026 Jul 1, 2026
Tamayo Louis Edward · Officer Grant (A) 12K
Owned 102K ΔOwn +13.4% Trade date Jun 29, 2026 Filed date Jul 1, 2026
Tamayo Louis Edward Officer Grant (A) 12K 102K +13.4% Jun 29, 2026 Jul 1, 2026
Otero Jose Manuel · Officer Grant (A) 12K
Owned 142K ΔOwn +9.3% Trade date Jun 29, 2026 Filed date Jul 1, 2026
Otero Jose Manuel Officer Grant (A) 12K 142K +9.3% Jun 29, 2026 Jul 1, 2026
Bhalla Narinder Pal · Officer Grant (A) 55K
Owned 104K ΔOwn +111.1% Trade date Jun 29, 2026 Filed date Jul 1, 2026
Bhalla Narinder Pal Officer Grant (A) 55K 104K +111.1% Jun 29, 2026 Jul 1, 2026
Townsend Richard Nolan · Director Grant (A) 67K
Owned 404K ΔOwn +19.9% Trade date Jun 29, 2026 Filed date Jul 1, 2026
Townsend Richard Nolan Director Grant (A) 67K 404K +19.9% Jun 29, 2026 Jul 1, 2026
Altschuler Steven · Director Grant (A) 35K
Owned 35K Trade date Jun 25, 2026 Filed date Jun 29, 2026
Altschuler Steven Director Grant (A) 35K 35K Jun 25, 2026 Jun 29, 2026
Agger Mette Kirstine · Director Grant (A) 35K
Owned 35K Trade date Jun 25, 2026 Filed date Jun 29, 2026
Agger Mette Kirstine Director Grant (A) 35K 35K Jun 25, 2026 Jun 29, 2026
Cooperstone Brenda · Director Grant (A) 35K
Owned 35K Trade date Jun 25, 2026 Filed date Jun 29, 2026
Cooperstone Brenda Director Grant (A) 35K 35K Jun 25, 2026 Jun 29, 2026
Diaz Reinaldo M. · Director Grant (A) 35K
Owned 35K Trade date Jun 25, 2026 Filed date Jun 29, 2026
Diaz Reinaldo M. Director Grant (A) 35K 35K Jun 25, 2026 Jun 29, 2026
Tanguler Tolga · Director Grant (A) 35K
Owned 35K Trade date Jun 25, 2026 Filed date Jun 29, 2026
Tanguler Tolga Director Grant (A) 35K 35K Jun 25, 2026 Jun 29, 2026
Van Hauwermeiren Timothy · Director Grant (A) 35K
Owned 35K Trade date Jun 25, 2026 Filed date Jun 29, 2026
Van Hauwermeiren Timothy Director Grant (A) 35K 35K Jun 25, 2026 Jun 29, 2026
Cholmondeley Paula H. · Director Grant (A) 35K
Owned 35K Trade date Jun 25, 2026 Filed date Jun 29, 2026
Cholmondeley Paula H. Director Grant (A) 35K 35K Jun 25, 2026 Jun 29, 2026
15 of 48
15 of 48 Sign in to continue to older insider transactions.

Lexeo Therapeutics, Inc. Common Stock (LXEO) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Balyasny Asset Management L.P. 7.2M
% of shares outstanding 9.7% Filing date May 15, 2026
Balyasny Asset Management L.P. 7.2M 9.7% May 15, 2026
Paradigm Biocapital Advisors LP 6.2M
% of shares outstanding 8.3% Filing date May 15, 2026
Paradigm Biocapital Advisors LP 6.2M 8.3% May 15, 2026
Citadel Advisors LLC 5.4M
% of shares outstanding 7.2% Filing date Feb 17, 2026
Citadel Advisors LLC 5.4M 7.2% Feb 17, 2026
Eventide Asset Management, LLC 1.9M
% of shares outstanding 5.6% Filing date Nov 14, 2024
Eventide Asset Management, LLC 1.9M 5.6% Nov 14, 2024
D1 Capital Partners L.P. 979K
% of shares outstanding 2.9% Filing date May 15, 2025
D1 Capital Partners L.P. 979K 2.9% May 15, 2025
Adage Capital Management, L.P. 238K
% of shares outstanding 0.7% Filing date May 12, 2025
Adage Capital Management, L.P. 238K 0.7% May 12, 2025
6 of 6

Lexeo Therapeutics, Inc. Common Stock (LXEO) ownership FAQ

Who owns LXEO?

138 reporting institutions disclosed LXEO position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.